incretin hormone glp-1 Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research The Influence of Glucagon-like Peptide-1

Akhondzadeh, S., Mostafavi, S

Consult Your Doctor if Symptoms Persist If side effects like nausea, vomiting, or diarrhoea persist for more than a few weeks, its important to consult your healthcare provider

Stylo injectable : la plupart des aGLP-1 sont administrs par injection sous-cutane, au niveau de labdomen, de la cuisse ou du bras

Click here Image Credit : Latest Developments in GLP-1 Receptor Agonist Therapies by PharmaCompass license under CC BY 2.0 The article is based on the information available in public and which the author believes to be true

GLP-1 also reduces appetite, while GIP may have a role in fat deposition and potentially mitigating some of the nausea associated with GLP-1 receptor agonists

Tirzepatide remains an outstanding, first-line agent for patients focused on achieving robust weight loss while mitigating the risk of Type 2 Diabetes